News

Cadila Pharmaceuticals has introduced 5-in-1 wonder pill – Polycap in the domestic market, reported Times of India. The new pill is expected to be a combination of five

Cardium Therapeutics has revealed that all patients enrolled in the MATRIX clinical study have completed their initial 12-week evaluation period. The company plans to provide detailed safety and

Amgen has reported the top-line results of phase 3 study of Aranesp. Aranesp is for the treatment of anemia associated with CRF for patients on dialysis and patients

An EUA authorizes the use of unapproved medical products or unapproved uses of approved medical products during a declared public health emergency. “The FDA worked quickly with the

Medicago has received clearance from Health Canada to commence a phase I human clinical trial with its H5N1 Avian Influenza vaccine. Enrollment of volunteers is currently underway. According

Cellceutix has acquired the rights to the compound KM 732, which shows properties in the reduction of high blood pressure. Preliminary testing in rats revealed that test animals

Nanosphere has submitted a 510(k) application to the FDA for its influenza and respiratory syncytial virus (RSV) test to run on the Verigene SP, with complete sample-to-result automation.

Delcath Systems, a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, has exceeded 90% enrollment (reaching 85 patients) for its

Sinochem Quanzhou Petrochemical (Sinochem Quanzhou) has selected UNIPOL Polypropylene Process Technology for its new 200 KTA polypropylene facility. The plant will be built in Quanzhou, Fujian Province in